Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase

Wright, Thomas

3 - Scientific Plenary
Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase

Saturday, March 22, 2014: 8:47 AM

Ballroom B/C (Tampa Convention Center)

T. C. Wright¹, M. H. Stoler², C. M. Behrens³, G. Zhang³ and A. Sharma³
¹Columbia University, New York, NY, ²University of Virginia Health System, Charlottesville, VA, ³Roche Molecular Systems, Pleasanton, CA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

3 - Scientific Plenary
Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase

3 - Scientific Plenary Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase

3 - Scientific Plenary
Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase